1. Home
  2. MREO vs DDD Comparison

MREO vs DDD Comparison

Compare MREO & DDD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mereo BioPharma Group plc

MREO

Mereo BioPharma Group plc

HOLD

Current Price

$0.46

Market Cap

324.6M

Sector

Health Care

ML Signal

HOLD

Logo 3D Systems Corporation

DDD

3D Systems Corporation

HOLD

Current Price

$2.21

Market Cap

373.9M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
MREO
DDD
Founded
2015
1986
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer peripheral equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
324.6M
373.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
MREO
DDD
Price
$0.46
$2.21
Analyst Decision
Buy
Buy
Analyst Count
6
2
Target Price
$3.90
$4.75
AVG Volume (30 Days)
21.9M
5.3M
Earning Date
11-10-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.10
Revenue
$500,000.00
$391,651,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$6,363.05
$1.31
P/E Ratio
N/A
$21.39
Revenue Growth
N/A
N/A
52 Week Low
$0.20
$1.32
52 Week High
$3.26
$5.00

Technical Indicators

Market Signals
Indicator
MREO
DDD
Relative Strength Index (RSI) 31.93 45.82
Support Level $0.42 $2.47
Resistance Level $0.78 $2.89
Average True Range (ATR) 0.08 0.20
MACD 0.04 -0.04
Stochastic Oscillator 10.72 4.86

Price Performance

Historical Comparison
MREO
DDD

About MREO Mereo BioPharma Group plc

Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).

About DDD 3D Systems Corporation

3D Systems Corp provides comprehensive 3D printing and digital manufacturing solutions, including 3D printers for plastics and metals, materials, software, and services, including maintenance, advanced manufacturing and applications engineering. The company's segments include Healthcare Solutions and Industrial Solutions. It generates maximum revenue from the Industrial segment. It conducts business through various offices and facilities located throughout the Americas, EMEA, and APAC; generating a vast majority of revenues from the Americas.

Share on Social Networks: